BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/4/2022 12:30:52 PM | Browse: 911 | Download: 2831
 |
Received |
|
2021-12-21 17:57 |
|
Peer-Review Started |
|
2021-12-21 17:58 |
|
First Decision by Editorial Office Director |
|
2022-03-10 07:35 |
|
Return for Revision |
|
2022-03-10 07:35 |
|
Revised |
|
2022-04-15 13:01 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-05-19 03:10 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-05-22 23:11 |
|
Articles in Press |
|
2022-05-22 23:11 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-06-28 11:45 |
|
Publish the Manuscript Online |
|
2022-07-04 12:30 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Basic Study |
| Article Title |
Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zu-Yin Li, Gang Wu, Qiu Chen, Zhi-Jie Zhou, Yu-Peng Wang, Guo-He Song, Chao Xiao, Xin Zhang, Gui-Long Deng, Rui-Tao Wang, Yu-Long Yang and Xiao-Liang Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81670514 |
| National Natural Science Foundation of China |
81702337 |
| Scientific Research Project of Shanghai Municipal Health Commission |
202040065 |
| Natural Science Foundation of Shanghai Scientific and Technological Project of Innovative Action |
20ZR1411900 |
|
| Corresponding Author |
Xiao-Liang Wang, PhD, Chief Doctor, Department of General Surgery, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, No. 1158 Park Road (E), Qingpu District, Shanghai 201700, China. xiaoliangwang2018@163.com |
| Key Words |
TM6SF2; Nonalcoholic fatty liver disease; Fatty acid metabolism; Treatment; MK-4074 |
| Core Tip |
In this study, we observed TM6SF2 overexpression in nonalcoholic fatty liver disease (NAFLD) cases. TM6SF2 overexpression can reduce hepatic lipid accumulation, suggesting a protective role for TM6SF2 in a high-fat diet. Meanwhile, there is an imbalance in the processes of uptake, synthesis, and intracellular expense of fatty acids in TM6SF2-deficient mouse models. Therefore, we propose possible therapeutic strategies for NAFLD caused by TM6SF2 deficiency. |
| Publish Date |
2022-07-04 12:30 |
| Citation |
Li ZY, Wu G, Qiu C, Zhou ZJ, Wang YP, Song GH, Xiao C, Zhang X, Deng GL, Wang RT, Yang YL, Wang XL. Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments. World J Gastroenterol 2022; 28(25): 2937-2954
|
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i25/2937.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i25.2937 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
